D.A. Davidson & CO. boosted its position in UiPath Inc. (NYSE:PATH – Free Report) by 60.1% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 557,667 shares of the company’s stock after purchasing an additional 209,300 shares during the period. D.A. Davidson & CO.’s holdings in UiPath were worth $7,138,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Pacer Advisors Inc. purchased a new position in UiPath in the 2nd quarter worth $69,180,000. Senvest Management LLC raised its position in UiPath by 16.7% in the 3rd quarter. Senvest Management LLC now owns 10,894,483 shares of the company’s stock worth $139,449,000 after purchasing an additional 1,559,500 shares during the period. Renaissance Technologies LLC purchased a new position in UiPath in the 2nd quarter worth $13,280,000. AQR Capital Management LLC raised its position in UiPath by 120.6% in the 2nd quarter. AQR Capital Management LLC now owns 1,633,393 shares of the company’s stock worth $20,385,000 after purchasing an additional 892,845 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in UiPath by 37.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,783,571 shares of the company’s stock worth $35,296,000 after purchasing an additional 754,519 shares during the period. 62.50% of the stock is currently owned by institutional investors.
UiPath Price Performance
NYSE:PATH opened at $14.09 on Thursday. UiPath Inc. has a one year low of $10.37 and a one year high of $27.87. The company’s 50-day simple moving average is $12.79 and its 200 day simple moving average is $13.04. The firm has a market capitalization of $7.75 billion, a P/E ratio of -70.45 and a beta of 0.87.
Analyst Ratings Changes
A number of brokerages recently commented on PATH. JPMorgan Chase & Co. decreased their target price on shares of UiPath from $19.00 to $17.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 23rd. Evercore ISI boosted their price objective on shares of UiPath from $13.00 to $16.00 and gave the company an “in-line” rating in a research report on Friday, September 6th. Bank of America boosted their price objective on shares of UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Wells Fargo & Company decreased their price objective on shares of UiPath from $15.00 to $13.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $16.00 price objective on shares of UiPath in a research report on Friday, September 6th. Sixteen investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $17.47.
View Our Latest Stock Analysis on UiPath
Insider Buying and Selling
In other UiPath news, CFO Ashim Gupta sold 47,671 shares of UiPath stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at approximately $10,258,498.19. The trade was a 5.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 22.37% of the stock is currently owned by insiders.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories
- Five stocks we like better than UiPath
- Buy P&G Now, Before It Sets A New All-Time High
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are the FAANG Stocks and Are They Good Investments?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is a support level?
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.